| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -249.1% | -83.5% |
| ROCE | 250.0% |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 10.3 | 8.8 |
| Pr/Book | n/a |
| Latest | F'cast | |
|---|---|---|
| Revenue | 50.4% | -52.4% |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-07 | 1.79 | (2.40) | (120.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-08 | 1.20 | (2.75) | (75.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-09 | 1.17 | (4.49) | (65.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-10 | 1.22 | (3.34) | (30.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-11 | 1.83 | (7.05) | (50.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-12 | 1.36 | (1.14) | (11.48)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-13 | 3.03 | 0.14 | 0.96p | 86.2 | n/a | n/a | n/a | 0.0% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
| New Generation Biomarker Products for CSF | 16-May-2012 | 07:00 | RNS-R |
| Holding(s) in Company | 14-May-2012 | 10:03 | RNS |
| Directorate Change | 08-May-2012 | 07:00 | RNS |
| Small caps round-up: FFastFill, Nasstar, SocialG... | 13-Mar-2012 | ShareCast |
| William Hill loses £26m on failed web relaunch | 11-Jan-2008 | Guardian |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 83.00p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 137.50p |
| 52 Week Low | 55.00p |
| Volume | 1,543 |
| Shares Issued | 14.49m |
| Market Cap | £12.03m |
| RiskGrade | 569 |
| Value | ![]() |
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 0 |
| Buy | 1 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |

| No dividends found |
| Time | Volume / Share Price |
| 12:17 | 1,143 @ 85.88p |
| 11:21 | 400 @ 82.00p |
| Finance Director | Frank Matthaei |
| CFO | Leif Hamø |
You are here: research